Kim Steegen

1.2k total citations
43 papers, 727 citations indexed

About

Kim Steegen is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Kim Steegen has authored 43 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 34 papers in Virology and 5 papers in Molecular Biology. Recurrent topics in Kim Steegen's work include HIV/AIDS drug development and treatment (37 papers), HIV Research and Treatment (34 papers) and HIV/AIDS Research and Interventions (31 papers). Kim Steegen is often cited by papers focused on HIV/AIDS drug development and treatment (37 papers), HIV Research and Treatment (34 papers) and HIV/AIDS Research and Interventions (31 papers). Kim Steegen collaborates with scholars based in South Africa, Netherlands and United States. Kim Steegen's co-authors include Wendy Stevens, Sergio Carmona, Maria A. Papathanasopoulos, Chris Verhofstede, Marleen Temmerman, Kishor Mandaliya, Jean Plum, Gert U. van Zyl, Lieven Stuyver and William MacLeod and has published in prestigious journals such as PLoS ONE, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

Kim Steegen

42 papers receiving 711 citations

Peers

Kim Steegen
Mariëtte E. Botes South Africa
Shujia Liang China
Raphael Lihana Kenya
Benjamin Chimukangara South Africa
Lingjie Liao China
Sarah E. Hudelson United States
Alexandre Storto France
Caterina Gori Italy
Charlotte Charpentier France
Rose Mougnutou Cameroon
Mariëtte E. Botes South Africa
Kim Steegen
Citations per year, relative to Kim Steegen Kim Steegen (= 1×) peers Mariëtte E. Botes

Countries citing papers authored by Kim Steegen

Since Specialization
Citations

This map shows the geographic impact of Kim Steegen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Steegen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Steegen more than expected).

Fields of papers citing papers by Kim Steegen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Steegen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Steegen. The network helps show where Kim Steegen may publish in the future.

Co-authorship network of co-authors of Kim Steegen

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Steegen. A scholar is included among the top collaborators of Kim Steegen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Steegen. Kim Steegen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Papathanasopoulos, Maria A., et al.. (2024). K103N, V106M and Y188L Significantly Reduce HIV-1 Subtype C Phenotypic Susceptibility to Doravirine. Viruses. 16(9). 1493–1493. 1 indexed citations
2.
Hunt, Gillian, Mukhlid Yousif, Leon Levin, et al.. (2023). Resistance is common in paediatric patients failing ART in South Africa. Journal of Antimicrobial Chemotherapy. 78(5). 1160–1167. 5 indexed citations
3.
Steegen, Kim, Gert U. van Zyl, Mathilda Claassen, et al.. (2023). Advancing HIV Drug Resistance Technologies and Strategies: Insights from South Africa’s Experience and Future Directions for Resource-Limited Settings. Diagnostics. 13(13). 2209–2209. 3 indexed citations
4.
Oosterhout, Joep J. van, Katherine Simon, Mina C. Hosseinipour, et al.. (2023). Virological Findings and Treatment Outcomes of Cases That Developed Dolutegravir Resistance in Malawi’s National HIV Treatment Program. Viruses. 16(1). 29–29. 4 indexed citations
5.
Steegen, Kim, et al.. (2022). Low-level viraemia despite emergence of dolutegravir-resistant variants. Southern African Journal of HIV Medicine. 23(1). 1398–1398. 4 indexed citations
6.
Scott, Lesley, et al.. (2022). Guidance for SARS-CoV-2 RNA-Based Molecular Assay Analytical Performance Evaluations. Methods in molecular biology. 2511. 99–115. 2 indexed citations
7.
Steegen, Kim, et al.. (2021). Preparing for the next pandemic: Lessons from rapid scale-up of SARS-CoV-2 testing in a South African high-throughput automated HIV molecular laboratory. International Journal of Infectious Diseases. 110. 1–3. 2 indexed citations
8.
Bester, Phillip Armand, et al.. (2019). PhyloPi: An affordable, purpose built phylogenetic pipeline for the HIV drug resistance testing facility. PLoS ONE. 14(3). e0213241–e0213241. 1 indexed citations
9.
Boender, T. Sonia, Cissy Kityo, Ragna S. Boerma, et al.. (2016). Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa. Journal of Antimicrobial Chemotherapy. 71(10). 2918–2927. 73 indexed citations
10.
Steegen, Kim, Maria A. Papathanasopoulos, Gert U. van Zyl, et al.. (2016). Prevalence of Antiretroviral Drug Resistance in Patients Who Are Not Responding to Protease Inhibitor–Based Treatment: Results From the First National Survey in South Africa. The Journal of Infectious Diseases. 214(12). 1826–1830. 20 indexed citations
11.
12.
Dorst, Bieke Van, Amelieke J. H. Cremers, Karolien Jans, et al.. (2014). Integration of clinical point-of-care requirements in a DNA microarray genotyping test. Biosensors and Bioelectronics. 61. 605–611. 1 indexed citations
13.
Lukhwareni, Azwidowi, et al.. (2013). Viral Tropism and Antiretroviral Drug Resistance in HIV-1 Subtype C-Infected Patients Failing Highly Active Antiretroviral Therapy in Johannesburg, South Africa. AIDS Research and Human Retroviruses. 30(3). 289–293. 8 indexed citations
14.
Aitken, Susan C., Carole L. Wallis, Kim Steegen, et al.. (2013). Evaluation of an affordable HIV-1 virological failure assay and antiretroviral drug resistance genotyping protocol. Journal of Virological Methods. 194(1-2). 300–307. 5 indexed citations
15.
Nauwelaers, David, Margriet Van Houtte, Kim Steegen, et al.. (2011). A Synthetic HIV-1 Subtype C Backbone Generates Comparable PR and RT Resistance Profiles to a Subtype B Backbone in a Recombinant Virus Assay. PLoS ONE. 6(5). e19643–e19643. 4 indexed citations
16.
17.
Steegen, Kim, Stanley Lüchters, Kenny Dauwe, et al.. (2009). Effectiveness of antiretroviral therapy and development of drug resistance in HIV-1 infected patients in Mombasa, Kenya. AIDS Research and Therapy. 6(1). 12–12. 18 indexed citations
18.
Steegen, Kim, Stanley Lüchters, Nancy De Cabooter, et al.. (2007). Evaluation of two commercially available alternatives for HIV-1 viral load testing in resource-limited settings. Journal of Virological Methods. 146(1-2). 178–187. 34 indexed citations
19.
Steegen, Kim, Els Demecheleer, Nancy De Cabooter, et al.. (2005). A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance. Journal of Virological Methods. 133(2). 137–145. 41 indexed citations
20.
Snoeck, J., Chiara Riva, Kim Steegen, et al.. (2005). Optimization of a genotypic assay applicable to all human immunodeficiency virus type 1 protease and reverse transcriptase subtypes. Journal of Virological Methods. 128(1-2). 47–53. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mariëtte E. Botes Breakdown of academic impact, for papers by Shujia Liang Breakdown of academic impact, for papers by Raphael Lihana Breakdown of academic impact, for papers by Benjamin Chimukangara Breakdown of academic impact, for papers by Lingjie Liao Breakdown of academic impact, for papers by Sarah E. Hudelson Breakdown of academic impact, for papers by Alexandre Storto Breakdown of academic impact, for papers by Caterina Gori Breakdown of academic impact, for papers by Charlotte Charpentier Breakdown of academic impact, for papers by Rose Mougnutou
Rankless by CCL
2026